7. Myozyme – $300,000 per year
The next drug called Myozyme, helps treat Pompe disease, which is an inherited syndrome that prevents the normal processing of glycogen into glucose, a simple sugar and energy source for cells.
The drug helps the body with this vital task, preventing a toxic buildup of glycogen throughout the body.
The medication is only available through special medical programs that ensure severe allergic reactions don’t take place during and up to three hours after the procedure.
Only about one in 40,000 people contract Pompe disease, which causes muscle weakness, life-threatening heart defects, and an enlarged liver and respiratory failure.
